142 related articles for article (PubMed ID: 381006)
1. Clinical evaluation of (-)eburnamonine in comparison with nicergoline in patients suffering from chronic brain ischemia.
Marolda M; Fragassi N; Buscaino GA
Eur Neurol; 1978; 17 Suppl 1():159-66. PubMed ID: 381006
[TBL] [Abstract][Full Text] [Related]
2. Therapy of chronic consequences of brain ischemia. Comparison between two drugs acting on brain circulation and metabolism.
Passeri M
Eur Neurol; 1978; 17 Suppl 1():150-8. PubMed ID: 381005
[TBL] [Abstract][Full Text] [Related]
3. [Current treatment of cerebrovascular disorder with vasoactive drugs].
Lebiediewa NW
Neurol Neurochir Pol; 1981; 15(4):417-21. PubMed ID: 6895779
[TBL] [Abstract][Full Text] [Related]
4. CBF changes after (-)eburnamonine infusion in patients with cerebrovascular insufficiency.
Gossetti B; Ventura M; Damiano M; Bait C; Zaccaria A
Eur Neurol; 1978; 17 Suppl 1():171-2. PubMed ID: 753632
[TBL] [Abstract][Full Text] [Related]
5. [Buflomedil and nicergoline in the targeted treatment of acute cerebral ischemia. Randomized comparative double blind study].
Bossi L
Minerva Med; 1985 May; 76(21):1005-18. PubMed ID: 3889723
[TBL] [Abstract][Full Text] [Related]
6. [Initial dyscirculatory encephalopathy in middle-aged and elderly patients (problems of early diagnosis and therapy)].
Man'kovskiĭ NB; Mints AIa; Karaban' IN
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(1):16-20. PubMed ID: 2718657
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness of nicergoline in the treatment of chronic cerebrovascular insufficiency (author's transl)].
Kaemmerer E
Nervenarzt; 1980 Jun; 51(6):368-72. PubMed ID: 7453888
[No Abstract] [Full Text] [Related]
8. A comparison of some of the pharmacological properties of the new eburnamenine derivative vindeburnol with those of vincamine, vinburnine, dihydroergotoxine mesilate and nicergoline.
Barzaghi F; Dragonetti M; Formento ML; Gueniau C; Nencioni A; Mantegazza P
Arzneimittelforschung; 1986 Oct; 36(10):1442-8. PubMed ID: 3814205
[TBL] [Abstract][Full Text] [Related]
9. [Value of nicergoline in postischemic cerebral resuscitation. An experimental study in the dog].
Cahn R; Weber S; Angignard J; Angignard D; Borzeix MG
Agressologie; 1987 Mar; 28(3):341-6. PubMed ID: 3618895
[No Abstract] [Full Text] [Related]
10. Medical therapy of cerebral ischemia. Vasoactive and eumetabolic therapy.
Strano A; Pinto A; Davì G; Novo S; Riolo F
Eur Neurol; 1978; 17 Suppl 1():144-9. PubMed ID: 753630
[TBL] [Abstract][Full Text] [Related]
11. [Controlled study with nicergoline and placebo in cerebral and peripheral vascular insufficiency in the aged].
Cascone A; Liverta C; Pollini C
Minerva Cardioangiol; 1978; 26(1-2):95-100. PubMed ID: 347330
[No Abstract] [Full Text] [Related]
12. Simultaneous study of haemodynamic, metabolic and behavioural sequelae in a model of cerebral ischaemia in aged rats: effects of nicergoline.
Le Poncin-Lafitte M; Grosdemouge C; Duterte D; Rapin JR
Gerontology; 1984; 30(2):109-19. PubMed ID: 6706123
[TBL] [Abstract][Full Text] [Related]
13. Experimental clinical studies on the effect of eburnamonine in cerebrovascular disorders.
Jansen W; O'Connolly M; Lehmann E; Mayer M
Pharmacopsychiatry; 1986 Sep; 19(5):389-94. PubMed ID: 3534902
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of demonstrated cerebral ischemia with nicergoline (Sermion)].
Karyofilis A
Ther Ggw; 1980 Dec; 119(12):1478-85. PubMed ID: 7466692
[No Abstract] [Full Text] [Related]
15. [Treatment of cerebrovascular deficiencies. Therapeutic evaluation from 129 cases using the double-blind method against placebo].
Bargheon J; Durocher AM; Lagrange M
Sem Hop; 1984 Jan; 60(3):169-74. PubMed ID: 6320441
[TBL] [Abstract][Full Text] [Related]
16. [The role of nicergoline in the symptomatic treatment of arterial hypertension and chronic cerebrovascular insufficiency. A study on 359 observations (author's transl)].
Dauverchain J
Arzneimittelforschung; 1979; 29(8a):1308-10. PubMed ID: 395956
[TBL] [Abstract][Full Text] [Related]
17. [Effect of nicergoline on the intellectual performance (author's transl)].
Donoso A; Santander M; Sarce H
Rev Med Chil; 1979 Sep; 107(9):817-9. PubMed ID: 396627
[No Abstract] [Full Text] [Related]
18. [Psychopathometric double blind study with nicergoline versus placebo in geriatric patients with slight transit syndromes].
Blaha L; Burkard G; Lehrl S; Kapinas K
Arzneimittelforschung; 1979; 29(8a):1295-301. PubMed ID: 395955
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of arterial hypertension in the elderly with an alpha-blocker: nicergoline (author's transl)].
Forette F; Varin D; Henry JF; Hervy MP
Nouv Presse Med; 1980 Dec; 9(48):3685-8. PubMed ID: 7005872
[TBL] [Abstract][Full Text] [Related]
20. Nicergoline in mild to moderate dementia. A multicenter, double-blind, placebo-controlled study.
Battaglia A; Bruni G; Ardia A; Sacchetti G
J Am Geriatr Soc; 1989 Apr; 37(4):295-302. PubMed ID: 2646350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
